Cellebrite DI (NASDAQ:CLBT) & Yext (NYSE:YEXT) Head to Head Survey

Yext (NYSE:YEXT) and Cellebrite DI (NASDAQ:CLBT) are both technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Risk & Volatility

Yext has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500.

Institutional & Insider Ownership

71.0% of Yext shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 7.8% of Yext shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Yext and Cellebrite DI”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yext	$446.58 million	1.70	$37.87 million	$0.17	45.09
Cellebrite DI	$475.67 million	6.63	$78.33 million	$0.22	57.45

Cellebrite DI has higher revenue and earnings than Yext. Yext is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Yext and Cellebrite DI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yext	5.90%	43.23%	7.50%
Cellebrite DI	11.43%	15.58%	8.29%

Analyst Ratings

This is a summary of current ratings and recommmendations for Yext and Cellebrite DI, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yext	0	5	0	0	2.00
Cellebrite DI	1	0	5	0	2.67

Yext presently has a consensus target price of $6.33, suggesting a potential downside of 17.37%. Cellebrite DI has a consensus target price of $16.70, suggesting a potential upside of 32.12%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Yext.

Summary

Cellebrite DI beats Yext on 10 of the 14 factors compared between the two stocks.

About Yext

Yext, Inc. is a technology company that helps organizations manage and improve their digital presence across search engines, websites, maps, social networks and other online services. Its platform is designed to provide accurate, consistent and up-to-date information about businesses, products, locations and services across digital channels. Yext’s offerings include tools for managing business listings, location and entity data, website content, customer reviews and digital search experiences. The company’s platform uses structured data and artificial intelligence to help businesses organize their information, respond to customer questions and deliver relevant answers through websites and other online interfaces.

About Cellebrite DI

Cellebrite DI Ltd. develops digital intelligence software and services that help organizations access, collect, preserve and analyze digital evidence. Its tools are used to investigate information from mobile devices, computers, cloud sources and other digital systems. The company’s offerings include its UFED platform for extracting data from digital devices, Physical Analyzer for examining and interpreting evidence, and analytics and case-management tools such as Pathfinder and Guardian. Customers include law enforcement, public safety, intelligence and defense agencies, as well as organizations in the private sector.